Nature

Several LDL receptor family proteins help yellow fever virus enter cells

Updated

Abstract

Genetic ablation of LRP4 impaired yellow fever virus (YFV) infection in cell cultures.

  • LRP4 was identified as a candidate entry receptor for YFV through a CRISPR-Cas9 screen.
  • Complementation or ectopic expression of LRP4 increased YFV infection.
  • Related viruses in the YFV antigenic complex also demonstrated LRP4-dependent infection.
  • LRP4 facilitated YFV entry by binding to a specific domain of the YFV envelope protein.
  • Decoy receptors based on LRP4, LRP1, and VLDLR were effective in neutralizing YFV infection in cell cultures and reducing viral burden in mice.
  • A genetic deficiency of LRP1 in human hepatocyte cultures resulted in decreased YFV infection.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Competing interests: M.S.D. is a consultant or on a scientific advisory board for Inbios, IntegerBio, Akagera Medicines, GlaxoSmithKline, Merck and Moderna. The Diamond laboratory has received unrelated funding support in sponsored research agreements from Vir Biotechnology, Bavarian Nordic and Moderna. J.E.C. is a former member of the scientific advisory boards of Gigagen (Grifols) and BTG International, has consulted for Moderna, is founder of IDBiologics and receives royalties from UpToDate. The Crowe laboratory received unrelated sponsored research agreements from IDBiologics during the conduct of the study.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free